salbutamol metered-dose inhaler (MDI) 100 micrograms/puff: 2 to 10 puffs every 20 minutes during the first hour. In children, use a spacer a (use face mask in children under 3 years). Single puffs should be given one at a time, let the child breathe 4 to 5 times from the spacer before repeating the procedure. A spacer can also be used in adults to increase effectiveness. prednisolone PO: one dose of 1 to 2 mg/kg (max. 50 mg) for children over 5 years and adults oxygen if SpO < 94% b . 2 If the attack is completely resolved: Observe the patient for 1 hour (4 hours if they live far from the health centre) then give outpatient treatment: salbutamol MDI for 24 to 48 hours (2 to 4 puffs every 4 to 6 hours depending on clinical evolution) and prednisolone PO (same dose as above once daily) to complete 5 days of treatment. Reassess after 1 to 2 days: address any identified risk factor, reassess need for salbutamol and long-term treatment. If the patient is already receiving long-term treatment, reevaluate the severity of the asthma (see Chronic asthma), review compliance and correct use of medications and adjust treatment if necessary. If the attack is only partially resolved, continue with salbutamol MDI (2 to 10 puffs every 1 to 4 hours) until symptoms subside. For children up to 5 years, administer one dose of prednisolone PO as above if symptoms recur within 3 to 4 hours. When the attack is completely resolved, proceed as above. If symptoms worsen or do not improve, treat as severe attack. Severe attack Hospitalise c ; place the patient in a 1/2 sitting position. Administer: oxygen to maintain SpO between 94 and 98% b . 2 salbutamol + ipratropium nebuliser solutions using a nebuliser (continue